Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2009

01-12-2009 | Original Article

A Functional SNP of the Interleukin-18 Gene Is Associated with the Presence of Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients

Authors: Yong Seok Kim, Jae Youn Cheong, Sung Won Cho, Kee Myung Lee, Jae Chul Hwang, Bermseok Oh, Kuchan Kimm, Jung A. Lee, Byung Lae Park, Hyun Sub Cheong, Hyoung Doo Shin, Jin Hong Kim

Published in: Digestive Diseases and Sciences | Issue 12/2009

Login to get access

Abstract

Background/Aim

The natural course of hepatitis B virus (HBV) infection is likely related to host immune factors. Interleukin-18 (IL-18) plays a significant role in immune defense. This study was undertaken to determine the association between the presence of hepatocellular carcinoma (HCC) and single-nucleotide polymorphisms (SNPs) in the IL-18 gene in HBV-infected patients.

Methods

Between March 2002 and December 2004, 730 Korean subjects were enrolled in two different groups: (1) chronic carrier without HCC (n = 637) and (2) HCC (n = 93). We analyzed SNPs at four polymorphic sites in the IL-18 gene at positions −667G>T, −148G>C, +8925C>G, and +13925A>C in the study subjects. To evaluate the functional significance of SNPs in the IL-18 gene promoter region, we performed a reporter gene assay in HepG2 and Hep3B cells transfected with different alleles.

Results

The IL-18 −148C allele, +8925G allele, +13925C allele, and haplotype 3 (TCGC) were associated with the presence of HCC in codominant and dominant models. Furthermore, functional analyses using the reporter gene assay revealed that the −148C allele conferred significantly lower promoter activity.

Conclusions

This study indicates that the −148C, +8925G, and +13925C alleles of the IL-18 gene are associated with the presence of HCC and the 148G>C SNP is functionally important in determining disease outcome.
Literature
1.
go back to reference Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88–91.CrossRefPubMed Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88–91.CrossRefPubMed
2.
go back to reference Kojima H, Aizawa Y, Yanai Y, et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol. 1999;162:5063–5069.PubMed Kojima H, Aizawa Y, Yanai Y, et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol. 1999;162:5063–5069.PubMed
3.
go back to reference Schiffer E, Housset C, Cacheux W, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology. 2005;41:307–314.CrossRefPubMed Schiffer E, Housset C, Cacheux W, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology. 2005;41:307–314.CrossRefPubMed
4.
go back to reference Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 1997;57:4557–4563.PubMed Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 1997;57:4557–4563.PubMed
5.
go back to reference Osaki T, Peron JM, Cai Q, et al. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol. 1998;160:1742–1749.PubMed Osaki T, Peron JM, Cai Q, et al. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol. 1998;160:1742–1749.PubMed
6.
go back to reference Coughlin CM, Salhany KE, Wysocka M, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest. 1998;101:1441–1452.CrossRefPubMed Coughlin CM, Salhany KE, Wysocka M, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest. 1998;101:1441–1452.CrossRefPubMed
7.
go back to reference Osaki T, Hashimoto W, Gambotto A, et al. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18). Gene Ther. 1999;6:808–815.CrossRefPubMed Osaki T, Hashimoto W, Gambotto A, et al. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18). Gene Ther. 1999;6:808–815.CrossRefPubMed
8.
go back to reference Chang CY, Lee J, Kim EY, et al. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. BMC Cancer. 2007;7:87.CrossRefPubMed Chang CY, Lee J, Kim EY, et al. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. BMC Cancer. 2007;7:87.CrossRefPubMed
9.
go back to reference Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003;12:2541–2546.CrossRefPubMed Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003;12:2541–2546.CrossRefPubMed
10.
go back to reference Shin HD, Park BL, Kim LH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003;12:901–906.CrossRefPubMed Shin HD, Park BL, Kim LH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003;12:901–906.CrossRefPubMed
11.
go back to reference Cheong JY, Cho SW, Lim SK, et al. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci. 2005;20:65–69.CrossRefPubMed Cheong JY, Cho SW, Lim SK, et al. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci. 2005;20:65–69.CrossRefPubMed
12.
go back to reference Cheong JY, Cho SW, Hwang IL, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163–1169.CrossRefPubMed Cheong JY, Cho SW, Hwang IL, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163–1169.CrossRefPubMed
13.
go back to reference Cheong JY, Cho SW, Chung SG, et al. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet. 2006;44:246–255.CrossRefPubMed Cheong JY, Cho SW, Chung SG, et al. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet. 2006;44:246–255.CrossRefPubMed
14.
go back to reference Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal. 1999;14:143–149.PubMed Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal. 1999;14:143–149.PubMed
15.
go back to reference Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet. 2001;9:969–972.CrossRefPubMed Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet. 2001;9:969–972.CrossRefPubMed
16.
go back to reference Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics. 1987;117:331–341.PubMed Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics. 1987;117:331–341.PubMed
17.
go back to reference Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989.CrossRefPubMed Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989.CrossRefPubMed
18.
go back to reference Park H, Byun D, Kim TS, et al. Enhanced IL-18 expression in common skin tumors. Immunol Lett. 2001;79:215–219.CrossRefPubMed Park H, Byun D, Kim TS, et al. Enhanced IL-18 expression in common skin tumors. Immunol Lett. 2001;79:215–219.CrossRefPubMed
19.
go back to reference Cho D, Song H, Kim YM, et al. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res. 2000;60:2703–2709.PubMed Cho D, Song H, Kim YM, et al. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res. 2000;60:2703–2709.PubMed
20.
go back to reference Kohyama M, Saijyo K, Hayasida M, et al. Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res. 1998;89:1041–1046.PubMed Kohyama M, Saijyo K, Hayasida M, et al. Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res. 1998;89:1041–1046.PubMed
21.
go back to reference Shiratori I, Suzuki Y, Oshiumi H, et al. Recombinant interleukin-12 and interleukin-18 antitumor therapy in a guinea-pig hepatoma cell implant model. Cancer Sci. 2007;98:1936–1942.CrossRefPubMed Shiratori I, Suzuki Y, Oshiumi H, et al. Recombinant interleukin-12 and interleukin-18 antitumor therapy in a guinea-pig hepatoma cell implant model. Cancer Sci. 2007;98:1936–1942.CrossRefPubMed
22.
go back to reference Kim YJ, Lee HS, Im JP, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med. 2003;35:196–202.PubMed Kim YJ, Lee HS, Im JP, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med. 2003;35:196–202.PubMed
23.
go back to reference Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 1993;178:1541–1554.CrossRefPubMed Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 1993;178:1541–1554.CrossRefPubMed
24.
go back to reference Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology. 1996;23:17–23.CrossRefPubMed Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology. 1996;23:17–23.CrossRefPubMed
25.
go back to reference Hashimoto W, Osaki T, Okamura H, et al. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol. 1999;163:583–589.PubMed Hashimoto W, Osaki T, Okamura H, et al. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol. 1999;163:583–589.PubMed
26.
go back to reference Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146–152.CrossRefPubMed Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146–152.CrossRefPubMed
27.
go back to reference Barbaux S, Poirier O, Godefroy T, et al. Differential haplotypic expression of the interleukin-18 gene. Eur J Hum Genet. 2007;15:856–863.CrossRefPubMed Barbaux S, Poirier O, Godefroy T, et al. Differential haplotypic expression of the interleukin-18 gene. Eur J Hum Genet. 2007;15:856–863.CrossRefPubMed
Metadata
Title
A Functional SNP of the Interleukin-18 Gene Is Associated with the Presence of Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients
Authors
Yong Seok Kim
Jae Youn Cheong
Sung Won Cho
Kee Myung Lee
Jae Chul Hwang
Bermseok Oh
Kuchan Kimm
Jung A. Lee
Byung Lae Park
Hyun Sub Cheong
Hyoung Doo Shin
Jin Hong Kim
Publication date
01-12-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0970-6

Other articles of this Issue 12/2009

Digestive Diseases and Sciences 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.